Wo

OTC products · Product label record

Wopres Wart Remover drug information

SALICYLIC ACID 45%
Guangzhou Huixue Biotechnology Co., Ltd. · TOPICAL

Product NDC: 87204-203

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameSALICYLIC ACID 45%
Labeler / manufacturerGuangzhou Huixue Biotechnology Co., Ltd.
RouteTOPICAL
Drug classDrug class not supplied in source label
Product NDC87204-203
Label effective date2026-09-07

Official product label reference

Wopres Wart Remover — Guangzhou Huixue Biotechnology Co., Ltd.

This page contains 9 source sections for SALICYLIC ACID 45%, topical route. Label set 5aef5afe-d3f3-4af8-e063-6394a90a28cb, version 1.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Purpose

For the removal of warts, including nlantar warts flat warts common warts, corns, and calluses.
Dosage and administration — label text
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth.
Warnings
For external use only. .Flammable Keep away from fire and flame. ·Keep out of reach of children. .Avoid contact with eyes, in case of contact, flush eyes with plenty c cool water. .Do not swallow, if swallowed, seek medical attention or contact a Poisor Control Center (1-800-222-1222) immediately.Children should use this product under adult supervision. .Avoid prolonged exposure to air during use as the substance may dissolve and crystallize easily. .Recap immediately after each use, Do not use if the cap is broken or missing.
Active ingredient
Salicylic Acid 45%
Inactive ingredient
Water, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Angustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract.
Child safety
While using this medicine
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth. 4. More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.
Do not use
On broken skin or the area around the eyes. On irritated skin or on any area that is infected or reddened.If you are allergic to any ingredient .On moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes. •If you have diabetes or poor blood circulation. . If you are pregnant or breastfeeding unless directed by a healthcare practitioner.
When to stop use and seek help
Discontinue use and consult a doctor if: .You become pregnant or are trying to become pregnant while using this nrnduct •Irritation or redness occurs worsens, or does not improve with continued use.

Official sources and product identifiers

Substances listed: SALICYLIC ACID

Package NDC codes

87204-203-01

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.